256 related articles for article (PubMed ID: 31418010)
21. Molecular basis of Williams-Beuren syndrome: TFII-I regulated targets involved in craniofacial development.
Makeyev AV; Bayarsaihan D
Cleft Palate Craniofac J; 2011 Jan; 48(1):109-16. PubMed ID: 20500075
[TBL] [Abstract][Full Text] [Related]
22. GTF2I hemizygosity implicated in mental retardation in Williams syndrome: genotype-phenotype analysis of five families with deletions in the Williams syndrome region.
Morris CA; Mervis CB; Hobart HH; Gregg RG; Bertrand J; Ensing GJ; Sommer A; Moore CA; Hopkin RJ; Spallone PA; Keating MT; Osborne L; Kimberley KW; Stock AD
Am J Med Genet A; 2003 Nov; 123A(1):45-59. PubMed ID: 14556246
[TBL] [Abstract][Full Text] [Related]
23. A transcriptomic study of Williams-Beuren syndrome associated genes in mouse embryonic stem cells.
De Cegli R; Iacobacci S; Fedele A; Ballabio A; di Bernardo D
Sci Data; 2019 Nov; 6(1):262. PubMed ID: 31695049
[TBL] [Abstract][Full Text] [Related]
24. Essential role of the N-terminal region of TFII-I in viability and behavior.
Lucena J; Pezzi S; Aso E; Valero MC; Carreiro C; Dubus P; Sampaio A; Segura M; Barthelemy I; Zindel MY; Sousa N; Barbero JL; Maldonado R; Pérez-Jurado LA; Campuzano V
BMC Med Genet; 2010 Apr; 11():61. PubMed ID: 20403157
[TBL] [Abstract][Full Text] [Related]
25. Cognitive-behavioral phenotypes of Williams syndrome are associated with genetic variation in the GTF2I gene, in a healthy population.
Crespi BJ; Hurd PL
BMC Neurosci; 2014 Nov; 15():127. PubMed ID: 25429715
[TBL] [Abstract][Full Text] [Related]
26. Intracisternal Gtf2i Gene Therapy Ameliorates Deficits in Cognition and Synaptic Plasticity of a Mouse Model of Williams-Beuren Syndrome.
Borralleras C; Sahun I; Pérez-Jurado LA; Campuzano V
Mol Ther; 2015 Nov; 23(11):1691-1699. PubMed ID: 26216516
[TBL] [Abstract][Full Text] [Related]
27. Expression of Gtf2ird1, the Williams syndrome-associated gene, during mouse development.
Palmer SJ; Tay ES; Santucci N; Cuc Bach TT; Hook J; Lemckert FA; Jamieson RV; Gunnning PW; Hardeman EC
Gene Expr Patterns; 2007 Feb; 7(4):396-404. PubMed ID: 17239664
[TBL] [Abstract][Full Text] [Related]
28. Loss of GTF2I promotes neuronal apoptosis and synaptic reduction in human cellular models of neurodevelopment.
Adams JW; Vinokur A; de Souza JS; Austria C; Guerra BS; Herai RH; Wahlin KJ; Muotri AR
Cell Rep; 2024 Mar; 43(3):113867. PubMed ID: 38416640
[TBL] [Abstract][Full Text] [Related]
29. Neuronal deletion of Gtf2i, associated with Williams syndrome, causes behavioral and myelin alterations rescuable by a remyelinating drug.
Barak B; Zhang Z; Liu Y; Nir A; Trangle SS; Ennis M; Levandowski KM; Wang D; Quast K; Boulting GL; Li Y; Bayarsaihan D; He Z; Feng G
Nat Neurosci; 2019 May; 22(5):700-708. PubMed ID: 31011227
[TBL] [Abstract][Full Text] [Related]
30. GTF2IRD1 in craniofacial development of humans and mice.
Tassabehji M; Hammond P; Karmiloff-Smith A; Thompson P; Thorgeirsson SS; Durkin ME; Popescu NC; Hutton T; Metcalfe K; Rucka A; Stewart H; Read AP; Maconochie M; Donnai D
Science; 2005 Nov; 310(5751):1184-7. PubMed ID: 16293761
[TBL] [Abstract][Full Text] [Related]
31. An atypical 7q11.23 deletion in a normal IQ Williams-Beuren syndrome patient.
Ferrero GB; Howald C; Micale L; Biamino E; Augello B; Fusco C; Turturo MG; Forzano S; Reymond A; Merla G
Eur J Hum Genet; 2010 Jan; 18(1):33-8. PubMed ID: 19568270
[TBL] [Abstract][Full Text] [Related]
32. Biallelic GTF2IRD1 variants in brothers with profound neurodevelopmental disorder: A possible novel disorder involving a critical gene for Williams syndrome.
Cummings CT; Starr LJ
Am J Med Genet A; 2023 Feb; 191(2):332-337. PubMed ID: 36308390
[TBL] [Abstract][Full Text] [Related]
33. Identification of GTF2IRD1, a putative transcription factor within the Williams-Beuren syndrome deletion at 7q11.23.
Franke Y; Peoples RJ; Francke U
Cytogenet Cell Genet; 1999; 86(3-4):296-304. PubMed ID: 10575229
[TBL] [Abstract][Full Text] [Related]
34. Comparison of TFII-I gene family members deleted in Williams-Beuren syndrome.
Hinsley TA; Cunliffe P; Tipney HJ; Brass A; Tassabehji M
Protein Sci; 2004 Oct; 13(10):2588-99. PubMed ID: 15388857
[TBL] [Abstract][Full Text] [Related]
35. Genetic contributions to visuospatial cognition in Williams syndrome: insights from two contrasting partial deletion patients.
Broadbent H; Farran EK; Chin E; Metcalfe K; Tassabehji M; Turnpenny P; Sansbury F; Meaburn E; Karmiloff-Smith A
J Neurodev Disord; 2014; 6(1):18. PubMed ID: 25057328
[TBL] [Abstract][Full Text] [Related]
36. Neuronal deletion of Gtf2i results in developmental microglial alterations in a mouse model related to Williams syndrome.
Bar E; Fischer I; Rokach M; Elad-Sfadia G; Shirenova S; Ophir O; Trangle SS; Okun E; Barak B
Glia; 2024 Jun; 72(6):1117-1135. PubMed ID: 38450767
[TBL] [Abstract][Full Text] [Related]
37. The early embryonic expression of TFII-I during mouse preimplantation development.
Enkhmandakh B; Bitchevaia N; Ruddle F; Bayarsaihan D
Gene Expr Patterns; 2004 Jan; 4(1):25-8. PubMed ID: 14678824
[TBL] [Abstract][Full Text] [Related]
38. Isolation and characterisation of GTF2IRD2, a novel fusion gene and member of the TFII-I family of transcription factors, deleted in Williams-Beuren syndrome.
Tipney HJ; Hinsley TA; Brass A; Metcalfe K; Donnai D; Tassabehji M
Eur J Hum Genet; 2004 Jul; 12(7):551-60. PubMed ID: 15100712
[TBL] [Abstract][Full Text] [Related]
39. A Common Polymorphism in a Williams Syndrome Gene Predicts Amygdala Reactivity and Extraversion in Healthy Adults.
Swartz JR; Waller R; Bogdan R; Knodt AR; Sabhlok A; Hyde LW; Hariri AR
Biol Psychiatry; 2017 Feb; 81(3):203-210. PubMed ID: 26853120
[TBL] [Abstract][Full Text] [Related]
40. Duplication of GTF2I results in separation anxiety in mice and humans.
Mervis CB; Dida J; Lam E; Crawford-Zelli NA; Young EJ; Henderson DR; Onay T; Morris CA; Woodruff-Borden J; Yeomans J; Osborne LR
Am J Hum Genet; 2012 Jun; 90(6):1064-70. PubMed ID: 22578324
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
